Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

AAN Foundation launches new PSA on finding cure for brain disease

With one in six people in the United States now affected by brain disease such as dementia, multiple sclerosis and epilepsy, the American Academy of Neurology Foundation is marking its 20th anniversary with the launch of a new public service announcement (PSA) to raise awareness about the need for more research to cure brain disease.

12 Oct 2011

Incoming dean of Weill Cornell receives 2011 ICS Honorary Lifetime Membership

Dr. Laurie Glimcher, the incoming dean of Weill Cornell Medical College, has received the 2011 International Cytokine Society (ICS) Honorary Lifetime Membership, the Society's highest honor, for her pivotal contributions to cytokine research, particularly as it relates to immune response.

12 Oct 2011

AFFiRiS receives MJFF grant for clinical study of AFFITOPE PD01

The Michael J. Fox Foundation (MJFF) today announced that it has awarded $1.5 million to AFFiRiS AG, a Vienna, Austria-based biotech company, for a clinical study of AFFITOPE PD01, a first-of-its-kind Parkinson's disease (PD) vaccine.

12 Oct 2011

Leg-crossers more likely to have good recovery after severe stroke

People who are able to cross their legs soon after having a severe stroke appear to be more likely to have a good recovery compared to people who can't cross their legs.

11 Oct 2011

New information about effects of aging on the brain

Research by biologists at the University of York and Hull York Medical School has revealed important new information about the way the brain is affected by age.

11 Oct 2011

Our brain may filter out negativity to provide a rosier picture: Study

A new study shows that a reason why optimists retain a positive outlook even in the face of reality could be that the brain rejects bad news. The study published in Nature Neuroscience adds that in some people, anything negative is practically ignored - with them retaining a positive world view.

10 Oct 2011

Tips on how to prevent unnecessary medication/supplement mishaps

Navigating the supplement and medication maze can get confusing especially when you have multiple prescriptions. It is important to organize yourself with your medications and supplements to prevent unnecessary mishaps.

7 Oct 2011

Hysterectomy increases brain iron levels in both men and women

The human body has a love-hate relationship with iron. Just the right amount is needed for proper cell function, yet too much is associated with brain diseases like Alzheimer's and Parkinson's.

7 Oct 2011

Complete Genomics, Scripps collaborate to unlock genetic secrets of lifelong health

Complete Genomics Inc., the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health.

4 Oct 2011

MR-guided focused ultrasound may effectively control essential tremor

In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.

4 Oct 2011

Strong connection between preterm birth and risk of epilepsy

Being born prematurely may increase your risk of developing epilepsy as an adult, according to a new study published in the October 4, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Three Georgia Tech projects to receive NSF's EFRI grants

The National Science Foundation (NSF) has awarded $6 million to fund three projects involving researchers from the Georgia Institute of Technology. Each four-year, $2 million grant was awarded through the NSF's Division of Emerging Frontiers in Research and Innovation.

30 Sep 2011

Cedars-Sinai to co-sponsor World Stem Cell Summit

Six leaders in stem cell research from the Cedars-Sinai Regenerative Medicine Institute will be key presenters at the world's largest interdisciplinary stem cell meeting Oct. 3-5 in Pasadena, Calif.

30 Sep 2011

MRI-based technique allows researchers to follow neural stem cells in vivo

Carnegie Mellon University biologists have developed an MRI-based technique that allows researchers to non-invasively follow neural stem cells in vivo.

30 Sep 2011

Prehypertension may increase risk of stroke

Even people with blood pressure that is slightly above normal may be at an increased risk of stroke, according to a review of studies published in the September 28, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Sep 2011

DaTscan aids doctors in diagnosing patients with Parkinson's disease

Fifty thousand to 60,000 new cases of Parkinson's disease are diagnosed in the United States each year. Central DuPage Hospital (CDH) in Winfield, Ill., is among the first medical centers in North America to be using a new technology called DaTscan, an imaging tool that aids doctors in diagnosing patients who demonstrate Parkinsonian symptoms, like Parkinson's disease.

29 Sep 2011

SanBio initiates SB623 Phase 1/2a clinical trial in ischemic stroke

SanBio, Inc. has announced that a patient at Stanford University Medical Center has become the first to be treated with SB623, a novel cell therapy for patients with disability resulting from ischemic stroke.

29 Sep 2011

Adamas begins ADS-5102 Phase 2/3 clinical trial in Parkinson's disease

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has initiated a Phase 2/3 clinical trial of its proprietary investigational drug ADS-5102 (amantadine HCl extended release) for the treatment of levodopa induced dyskinesia (LID) in patients with Parkinson's disease.

28 Sep 2011

IUPUI develops mathematical model of brain's neural circuitry

Researchers from the School of Science at Indiana University-Purdue University Indianapolis have developed a mathematical model of the brain's neural circuitry that may provide a better understanding of how and why information is not transmitted correctly in the brains of Parkinson's disease patients. This knowledge may eventually help scientists and clinicians correct these misfires.

28 Sep 2011